Alexion Pharma Nordics AB
Pioneering transformative medicines for the global rare disease community.
Overview
- 10–19
- Employees
- 50–100M SEK
- Revenue
- 2011
- Founded
Key Decision Makers
Marc Dunoyer
Chief Executive Officer
Scott Weintraub
SVP, United States Business
Shane Doyle
SVP, Head of Operations
Soraya Bekkali
SVP, EUCAN and International Business
+16 more contacts in Funnelfeedr
Description
Alexion, operating as AstraZeneca Rare Disease, is fundamentally dedicated to pioneering new possibilities for the global rare disease community. Their core mission revolves around transforming the lives of people affected by rare conditions through the development of transformative treatments and m...